ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
7160 Evaluation of adverse event -related hospitalizations in patients with advanced renal cell carcinoma on treatment with temsirolimus or interferon-alfa: results from a phase 3 randomized trial
European Journal of Cancer Supplements
◽
10.1016/s1359-6349(09)71493-4
◽
2009
◽
Vol 7
(2)
◽
pp. 441
Author(s):
S. Rajagopalan
◽
E. Pullenayegum
◽
E. Alemao
◽
A. Strahs
◽
J. Purvis
Keyword(s):
Renal Cell Carcinoma
◽
Adverse Event
◽
Randomized Trial
◽
Cell Carcinoma
◽
Renal Cell
◽
Interferon Alfa
◽
Advanced Renal Cell Carcinoma
◽
Phase 3
Download Full-text
Related Documents
Cited By
References
7159 Loss of work activity and productivity in caregivers attending to patients with advanced renal cell carcinoma treated with temsirolimus or interferon-alfa: evaluations from a phase 3 randomized trial
European Journal of Cancer Supplements
◽
10.1016/s1359-6349(09)71492-2
◽
2009
◽
Vol 7
(2)
◽
pp. 441
Author(s):
E. Alemao
◽
S. Yang
◽
J. Purvis
Keyword(s):
Renal Cell Carcinoma
◽
Randomized Trial
◽
Cell Carcinoma
◽
Renal Cell
◽
Interferon Alfa
◽
Advanced Renal Cell Carcinoma
◽
Phase 3
◽
Work Activity
Download Full-text
Interleukin-2- and interferon alfa-2a-based immunochemotherapy in advanced renal cell carcinoma: A Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). Atzpodien J, Kirchner H, Jonas U, Bergmann L, Schott H, Heynemann H, Fornara P, Loening SA, Roigas J, Muller SC, Bodenstein H, Pomer S, Metzner B, Rebmann U, Oberneder R, Siebels M, Wandert T, Puchberger T, Reitz M, Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN), Medizinische Hochschule Hannover, Germany.
Urologic Oncology Seminars and Original Investigations
◽
10.1016/j.urolonc.2004.07.002
◽
2004
◽
Vol 22
(5)
◽
pp. 432
Author(s):
Donald L. Trump
Keyword(s):
Renal Cell Carcinoma
◽
Randomized Trial
◽
Cell Carcinoma
◽
Renal Cell
◽
Renal Carcinoma
◽
Interleukin 2
◽
Interferon Alfa
◽
Advanced Renal Cell Carcinoma
Download Full-text
7134 Evaluation of quality of life in patients with advanced renal cell carcinoma treated with temsirolimus vs interferon-alfa: results from a phase III randomized trial
European Journal of Cancer Supplements
◽
10.1016/s1359-6349(09)71467-3
◽
2009
◽
Vol 7
(2)
◽
pp. 433
◽
Cited By ~ 3
Author(s):
S. Yang
◽
G. Hudes
◽
P. deSouza
◽
E. Alemao
◽
A. Strahs
◽
...
Keyword(s):
Quality Of Life
◽
Renal Cell Carcinoma
◽
Randomized Trial
◽
Cell Carcinoma
◽
Renal Cell
◽
Interferon Alfa
◽
Phase Iii
◽
Advanced Renal Cell Carcinoma
Download Full-text
PCN126 LOSS OF WORK ACTIVITY AND PRODUCTIVITY IN CAREGIVERS ATTENDING TO PATIENTS WITH ADVANCED RENAL CELL CARCINOMA TREATED WITH TEMSIROLIMUS OR INTERFERON-ALFA: EVALUATIONS FROM A PHASE 3 RANDOMIZED TRAIL
Value in Health
◽
10.1016/s1098-3015(10)74377-1
◽
2009
◽
Vol 12
(7)
◽
pp. A281
◽
Cited By ~ 1
Author(s):
S Yang
◽
E Alemao
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Renal Cell
◽
Interferon Alfa
◽
Advanced Renal Cell Carcinoma
◽
Phase 3
◽
Work Activity
Download Full-text
Interleukin-2- and interferon alfa-2a-based immunochemotherapy in advanced renal cell carcinoma: A Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). Atzpodien J, Kirchner H, Jonas U, Bergmann L, Schott H, Heynemann H, Fornara P, Loening SA, Roigas J, Muller SC, Bodenstein H, Pomer S, Metzner B, Rebmann U, Oberneder R, Siebels M, Wandert T, Puchberger T, Reitz M, Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN), Medizinische Hochschule Hannover, Germany.J Clin Oncol 2004;22:1188–94
Urologic Oncology Seminars and Original Investigations
◽
10.1016/s1078-1439(04)00143-7
◽
2004
◽
Vol 22
(5)
◽
pp. 432-432
Author(s):
D TRUMP
Keyword(s):
Renal Cell Carcinoma
◽
Randomized Trial
◽
Cell Carcinoma
◽
Clin Oncol
◽
Renal Cell
◽
Renal Carcinoma
◽
Interleukin 2
◽
Interferon Alfa
◽
Advanced Renal Cell Carcinoma
Download Full-text
Faculty Opinions recommendation of Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.1119981.576105
◽
2008
◽
Author(s):
Sharokh Shariat
◽
Jose Karam
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Renal Cell
◽
Interferon Alfa
◽
Advanced Renal Cell Carcinoma
Download Full-text
Faculty Opinions recommendation of Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.13484037.14861147
◽
2012
◽
Author(s):
Thomas Powles
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Renal Cell
◽
Comparative Effectiveness
◽
Advanced Renal Cell Carcinoma
◽
Phase 3
Download Full-text
TIVO-3: A Phase 3, Randomised, Open-Label Study Comparing Tivozanib to Sorafenib in Patients with Advanced Renal Cell Carcinoma
SSRN Electronic Journal
◽
10.2139/ssrn.3427299
◽
2019
◽
Author(s):
Brian Rini
◽
Sumanta K. Pal
◽
Bernard J. Escudier
◽
Michael B. Atkins
◽
Thomas E. Hutson
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Renal Cell
◽
Advanced Renal Cell Carcinoma
◽
Open Label
◽
Phase 3
◽
Open Label Study
◽
Label Study
Download Full-text
Re: Comparative Effectiveness of Axitinib versus Sorafenib in Advanced Renal Cell Carcinoma (AXIS): A Randomised Phase 3 Trial
The Journal of Urology
◽
10.1016/j.juro.2012.04.069
◽
2012
◽
Vol 188
(2)
◽
pp. 412-413
Author(s):
Samir S. Taneja
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Renal Cell
◽
Comparative Effectiveness
◽
Advanced Renal Cell Carcinoma
◽
Phase 3
Download Full-text
Re: Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
European Urology
◽
10.1016/j.eururo.2008.09.037
◽
2009
◽
Vol 55
(1)
◽
pp. 250-252
◽
Cited By ~ 3
Author(s):
Shahrokh F. Shariat
◽
Jose A. Karam
◽
Pierre I. Karakiewicz
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Renal Cell
◽
Interferon Alfa
◽
Advanced Renal Cell Carcinoma
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close